期刊文献+

胆固醇酯转运蛋白水平与冠心病患者血脂指标的相关性 被引量:7

A Study on Correlation between Cholesteryl Ester Transfer Protein and Coronary Heart Disease
下载PDF
导出
摘要 目的探讨血浆胆固醇酯转运蛋白(CETP)对冠心病(CHD)患者相关血脂指标的影响。方法行冠状动脉造影的患者550例,根据冠状动脉造影结果分为CHD组(n=430)和正常组(n=120)。测定2组血浆CETP、总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、载脂蛋白A1(ApoA1)、载脂蛋白B(ApoB)及ApoA1/ApoB水平。结果 CHD组患者血浆中HDL-C、ApoA1及ApoA1/ApoB的水平显著低于正常组(P<0.01);CETP水平在CHD组与正常组间差异无统计学意义,CETP水平与HDL-C和ApoA1值呈负相关(rs分别为-0.141和-0.165,P<0.05);多因素Logistic回归分析显示,CETP不是CHD的独立影响因素。结论 CETP虽然不是冠心病的影响因素,但是为以后通过干预CETP来调节血脂并治疗冠心病提供了一定的临床数据资料。 Objective To investigate the effect of cholesteryl ester transfer protein (CETP) on lipid parameters in pa- tients with coronary heart disease (CHD). Methods Five hundred and fifty-five cases were divided into CHD group (n= 430) and control group (n=120) according to the result of coronary angiography (CAG). The plasma levels of CETP, total cholesterol (TC), triglyeeride (TG), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), apolipoprotein A1 (ApoA1), apolipoprotein B (ApoB) and ApoA1/ApoB were measured and analyzed respectively in two groups. Results The values of HDL-C, ApoA1 and ApoA1/ApoB were significantly lower in CHD group compared with those of control group (P 〈 0.01). There was no significant difference in the level of CETP between two groups, but the level of CETP was negatively correlated with the levels of HDL-C and ApoA1 (rn= -0.141 and rs= -0.165 ,P 〈 0.05). The multivari- ate logistic regression analysis showed that CETP level was not independent risk factors of CHD.Conclusion Although CETP was not influencing factors of coronary heart disease, this study provided clinical data for regulating blood lipids and treatment of coronary heart disease by the intervention of CETP.
出处 《天津医药》 CAS 北大核心 2013年第6期572-575,共4页 Tianjin Medical Journal
基金 天津市卫生局科技基金资助项目(项目编号:2011KZ62)
关键词 冠心病 胆固醇酯转运蛋白质类 胆固醇 HDL 载脂蛋白A-Ⅰ 危险因素 统计学 非参数 coronary disease cholesterol ester transfer proteins cholesterol, HDL apolipoprotein A- I risk factors statistics, nonparametric
  • 相关文献

参考文献13

  • 1Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investiga- tors [J]. N Engl J Med, 1996, 335(14): 1001-1009.
  • 2Tall AR. CETP inhibitors to increase HDL cholesterol levels [J]. N Engl J Med, 2007, 356(13): 1364-1366.
  • 3de Grooth GJ, Klerkx AH, Stroes ES, et al. A review of CETP and its relation to atherosclerosis [J]. J Lipid Res, 2004, 45(11): 1967-1974.
  • 4Neaton JD, Wentworth D. Serum cholesterol, blood pressure, ciga- rette smoking, and death from coronary heart disease. Overall find- ings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group [J]. Arch Intern Med, 1992, 152(1): 56-64.
  • 5徐成斌.血脂异常的药物治疗新进展[J].中华心血管病杂志,2001,29(3):189-192. 被引量:84
  • 6Eren E, Yilmaz N, Aydin O. High Density Lipoprotein and it' s Dys- function [J]. Open Biochem J, 2012, 6(7): 78-93.
  • 7Ahmad T, Chasman DI, Buring JE, et al. Physical activity modifies the effect of LPL, LIPC, and CETP polymorphisms on HDL-C lev- els and the risk of myocardial infarction in women of European an- cestry [J]. Circ Cardiovasc Genet, 2011, 4(1): 74-80.
  • 8Shinkai H. Cholesteryl ester transfer-protein modulator and inhibi- tors and their potential for the treatment of cardiovascular diseases [J]. Vase Health Risk Manag, 2012, 8(5): 323-331.
  • 9Briand F. The use of dyslipidemic hamsters to evaluate drug-in-duced alterations in reverse cholesterol transport [J]. Curr Opin In- vestig Drugs, 2010, 11(3): 289-297.
  • 10Redondo S, Martinez-Gonzalez J, Urraca C, et al. Emerging thera- peutic strategies to enhance HDL function [J]. Lipids Health Dis, 2011, 10(10): 175.

二级参考文献9

  • 1Tall AR. Cholesteryl ester transfer protein[J].J Lipid Res, 1995,6:306-311.
  • 2Ordovas JM, Adrienne Cupples L, Corella D, et al. Association of cholesterol ester transfer protein-Taq I B polymorphism with variations in lipoprotein subclasses and coronary heart disease risk[J]. Arterioscler Thromb Vasc Biol,2000,20:1323-1329.
  • 3Corella D, Saiz C, Guillen M, et al. Association of Taq I B polymorphism in the eholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population [ J ]. Atherosclerosis, 2000, 152:367-375.
  • 4Kuivenhoven JA, Knijff P, Boer JMA, et al. Heterogeneity at the CE3P gene locus. Influence on plasma CETP concentrations and HDL cholesterol levels [ J ]. Arteriescler Thromb Vasc Biol, 1997, 17 : 560-568.
  • 5Kanma H, Savolainen MJ, Heikkila R, et al. Sex difference in the regulation of plasma high density lipoprotein cholesterol by genetic and environment factors[ J ]. Hum Genet, 1996,97 : 156-162.
  • 6Kuivenhoven JA, Jukema JW, Zwinderman AH, et al. The role of a common variant of the cholesterol ester transfer protein gene in the progression of coronary atherosclerosis[ J]. New Engl J Med, 1998,338:86-93.
  • 7Kark JD, Sinmeich R, Leitersdorf E, et al. Taq I B CETP polymorphism, plasma CETP, lipoproteins, apolipoproteins and sex differences in a Jewish population sample characterized by low HDL-cholesterol[J]. Atherosclerosis,2000, 151:509-518.
  • 8Zhuang YY, Wang JJ, Qiang HI, et al. Serum cholesteryl ester transfer protein concentration in healthy Chinese subjects and cardio-cerebrovascular disease patients[ J ]. Clin Chim Acta, 2001,305 : 19-25.
  • 9Fumeon F, Betoulle D, Luc G, et al. Alcohol intake modulates the effect of a polymorphisms of the cholesteryl ester transfer protein gene on plasma high density hpoprotein and the risk of myocardial infarction[J]. J Clin Invest, 1995,96:1664-1671.

共引文献87

同被引文献30

引证文献7

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部